The upgrade from JP Morgan is a positive signal for Healthcare Realty Trust. It indicates that the analyst believes the company's stock is likely to outperform. The price target of $19 also suggests potential upside from the current price. This could lead to increased investor interest and potentially a short-term increase in the stock price.